Hangzhou, China · Founded 2020 · Privately Held (backing)
Provider and developer of biological proteins used as medications. JHM Biopharma is based in Hangzhou, China and was founded in 2020. Its last reported valuation was $160 million in May 2024. It has raised $84.8 million.
Last reported valuation
$159.7M
Oct 2026
Priced at
—
Total raised
$84.8M
Last round
—
Cap table — not yet on record
JHM Biopharma's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of JHM Biopharma with a free account
·The complete investor list: 13 names
·Watch JHM Biopharma: the Monday email on marks, rounds and moves
